Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT04545320
Other study ID # 303005-RF008-CB
Secondary ID
Status Withdrawn
Phase N/A
First received
Last updated
Start date September 1, 2020
Est. completion date October 31, 2022

Study information

Verified date November 2022
Source The University of Hong Kong
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Obesity is a major risk factor for cardiovascular disease and diabetes as well as all-cause mortality. The prevalence of obesity has continuously increased in most countries and has doubled in over 70 countries since 1980. The World Health Organization (WHO) estimated in 2014 that ~600 million (13%) adults were obese and ~1.9 billion (39%) were overweight worldwide. Notably, United States and China have the highest numbers of obese adults. According to a national survey in China in 2014 conducted among 146,703 Chinese adults aged 20-59, the prevalence of obesity was 13%, central obesity was 25% and overweight was 41%. In Hong Kong, the Behavioural Risk Factor Survey conducted by the Government in 2016 found 39% of adults were classified as overweight or obese, of which 21% were obese. The prevalence of central obesity has also risen steadily since 1999 in America. By 2030 is projected to reach 55.6% in men, 80.0% in women, 47.6% among girls and 38.9% among boys in the United States. Overweight, obesity and central obesity are now already pandemic public health issues causing heavy burden on healthcare system. Nowadays, lifestyle modification interventions still remain as the primary strategy to manage obesity and obesity-related complications, among which exercise is low-cost and effective. Substantial evidences have demonstrated effectiveness of HIIT and MICT in reducing body adiposity and improving body Anthropometry. However, studies have also pointed out "lack of time" is one of the major barriers preventing patients from exercise participation. Therefore, studies have put focus on low-frequency or low-volume exercise in improving health to reduce time commitment and increase exercise adherence. Among substantial evidence, our recent study demonstrated once-a-week HIIT is effectively in improving body composition. The effectiveness of low-frequency exercise in reducing visceral fat has also been explored. However, a recent meta-analysis showed low-frequency exercise is not effective in reducing visceral fat. Notably, the authors pointed out most of studies included in the meta-analysis adopted cycling exercise modality and they suggested walking or running exercise which recruits more body muscles may exert better results. In this study, we propose to adopt walking exercise modality to fill the research gap identified by the meta-analysis. Also, no study has compared the effectiveness of low-frequency HIIT and MICT in reducing visceral fat determined by magnetic resonance imaging (MRI) previously. Study aim: to examine the effectiveness of once-a-week high-intensity interval training (HIIT) versus moderate-intensity continuous training (MICT) in reducing visceral fat in adults with central obesity


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date October 31, 2022
Est. primary completion date October 31, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria: 1. Adults aged 18 - 60, 2. Central obesity, defined as BMI =25 (obesity classification adopted by the Hong Kong Government) with waist circumference of =90 cm for men and =80 cm for women (abdominal obesity according to the International Diabetes Federation's Chinese ethnic-specific criterion), 3. Males and females will be included to enhance generalizability. Exclusion Criteria: 1. =150 minutes moderate-intensity or =75 minutes vigorous-intensity exercise weekly, 2. Regular HIIT or MICT (=1 weekly) in the past 6 months, 3. Medical history of cardiovascular disease, chronic pulmonary or kidney disease, heart failure, cancer, etc., 4. Somatic conditions that limit exercise participation (e.g., limb loss), 5. Impaired mobility due to chronic diseases (e.g., chronic arthritis/osteoarthritis, neurological, musculoskeletal and autoimmune diseases), 6. Daily smoking and drinking habit, 7. Surgery, therapy or medication for obesity or weight loss in the past 6 months (e.g., gastric bypass, gastric band, sleeve gastrectomy, gastric reduction duodenal switch, and dietitian-prescribed dietary program).

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Usual care control group
Health education
HIIT group
Once-a-week HIIT
MICT group
Once-a-week MICT

Locations

Country Name City State
Hong Kong Li Ka Shing Faculty of Medicine, The University of Hong Kong Hong Kong

Sponsors (1)

Lead Sponsor Collaborator
The University of Hong Kong

Country where clinical trial is conducted

Hong Kong, 

Outcome

Type Measure Description Time frame Safety issue
Primary Visceral fat The amounts of visceral fat (VAT) at the abdominal region will be assessed by a 1.5-Teala whole-body scanner. A breath-hold localizer scan will be performed prior to the MRI scan. T1-weighted in-phase images will be obtained by fast spoiled gradient-echo sequences during suspended end-expiration. The VAT and between the thoracic diaphragm and the upper broader of the first sacral vertebra will be manually marked on each transverse image to calculate the volume of abdominal VAT. 3-month follow-up
Secondary Subcutaneous fat The amounts of subcutaneous fat (SAT) at the abdominal region will be assessed by a 1.5-Teala whole-body scanner. A breath-hold localizer scan will be performed prior to the MRI scan. T1-weighted in-phase images will be obtained by fast spoiled gradient-echo sequences during suspended end-expiration. The SAT between the thoracic diaphragm and the upper broader of the first sacral vertebra will be manually marked on each transverse image to calculate the volume of abdominal SAT. 3-month follow-up
Secondary Body fat mass Total body fat mass will be determined using a full body dual-energy X-ray absorptiometry (DXA) scanner (Explorer S/N 91075, Hologic Inc., Waltham, USA). A trained technician who is blinded to the group allocation will perform the tests and analyze the results. 3-month follow-up
Secondary Body fat percentage Total body fat percentage will be determined using a full body dual-energy X-ray absorptiometry (DXA) scanner (Explorer S/N 91075, Hologic Inc., Waltham, USA). A trained technician who is blinded to the group allocation will perform the tests and analyze the results. 3-month follow-up
Secondary Body Mass Index BMI will be determined by the equation BMI (kg/m2) = bodyweight/height^2. A calibrated electronic balance(UC-321,A&D Weighing, Australia, 150 kg capacity, ± 0.05 kg accuracy) and a stadiometer (Seva 231, Seca, Germany, 205 cm limit, ± 0.05 cm accuracy; ) will be used for the measurements. 3-month follow-up
Secondary Waist Circumference 1 Waist circumference will be measured on bare skin midway between the lowest rib and the superior border of the iliac crest using an inelastic measuring tape (Seca 201, Seca, Germany) to the nearest 0.1 cm following the WHO guideline. Measurement will be performed at the end of normal expiration. 3-month follow-up
Secondary Waist Circumference 2 Waist circumference will be measured on bare skin following the National Institutes of Health (NIH) guideline method (the superior border of the iliac crest)using an inelastic measuring tape (Seca 201, Seca, Germany) to the nearest 0.1 cm. Measurement will be performed at the end of normal expiration. 3-month follow-up
Secondary Cardiorespiratory fitness A maximal exercise test adopting the modified Bruce protocol will be be conducted to determine the maximal oxygen uptake (VO2max) of the subjects. The test will be conducted on a calibrated motor-driven treadmill with continuous metabolic VO2 measurement using a COSMED Quark CPET gas analysis system. 3-month follow-up
Secondary Bone Mineral Density Bone mineral density will be simultaneously determined during the DXA scan for total body fat mass. 3-month follow-up
Secondary Lean Mass Lean mass will be simultaneously determined during the DXA scan for total body fat mass. 3-month follow-up
Secondary Health-related Quality of Life The validated Chinese version 12-item short form survey measures health-related quality of life covering physical functioning, emotional and mental health, bodily pain, general health, vitality, and social functioning. A higher overall score indicates better quality of life. 3-month follow-up
Secondary Adherence Class attendance will be analysed to indicate adherence to the interventions. 3-month follow-up
Secondary Adverse Events Adverse events will be closely monitored regularly by athletic coaches and research personnel, and by subjects' voluntary reports. Adverse events will be recorded as a secondary outcome. 3-month follow-up
Secondary Medication Detailed information (e.g., drug name, type, dose and daily frequency) on the use of dyslipidemic and hypertensive medications will be recorded at baseline. Subjects altering the dosage of medications after consultation with their physician over the study period will also be recorded as a secondary outcome. The lowest recommended dose (LRD) for 7 days will be used for the analysis. 3-month follow-up
Secondary Habitual Physical Activity Actigraph activity monitor (wGT3X-BT, Actigraph, USA) worn at the wrist region for 24 h over 7 consecutive days will be used to objectively determine habitual daily physical movement/activities. 3-month follow-up
Secondary Dietary Intake Habitual dietary intake will be assessed by 3-day food diary using an electronic scale (KD-400, Tanita, Japan)to determine the daily caloric intake and the relative proportions of macronutrients (carbohydrate, fat, and protein). 3-month follow-up
Secondary Blood pressure Blood pressure will be obtained at the same day with blood collection. Subjects will visit our laboratory in the morning after 10 hours of overnight fasting in order to retrain from consuming caffeine, alcohol, and blood pressure drugs at least 10 hours before the assessment. After 10 minutes of seated rest, blood pressure will be measured on the left arm using a sphygmomanometer. Systolic and diastolic blood pressure and mean arterial pressure will be obtained over the brachial artery region with the arm supported at the heart level using an appropriately sized cuff. Three measurements will be taken with a one-minute interval, and the average value will be recorded for analysis. 3-month follow-up
Secondary Hip circumference Hip circumference will be be taken on bare skin around the widest portion of the buttocks using an inelastic measuring tape (Seca 201, Seca, Germany) to the nearest 0.1 cm and the tape should be placed parallel to the floor. 3-month follow-up
Secondary Self-report habitual physical activity Self-report habitual physical activity will be measured by International Physical Activity Questionnaire (IPAQ). Higher scores indicate higher level of physical activity. 3-month follow-up
Secondary Enjoyment Enjoyment towards exercise will be quantitatively measured by the Physical Activity Enjoyment Scale. This Chinese scale has an overall score from 18 to 126. While a higher score indicates higher level of enjoyment towards the exercise. 3-month follow-up
See also
  Status Clinical Trial Phase
Completed NCT02375113 - Soy as an Innovative Dietary Component in Abdominal Obesity Management Amongst Peri- and Early Menopausal Women N/A
Completed NCT04807959 - Evaluation of the Effectiveness of a Comprehensive Visceral Adiposity-Focused Anti-Obesity Program
Completed NCT03665961 - The Association Between Microbiota, Endotoxaemia and the Host Obesity/ Insulin Resistance (MiPOOP Study)
Recruiting NCT05833009 - Acupuncture Treatment for Schizophrenia-related Central Obesity N/A
Completed NCT01881373 - Children's Healthy Living Community Randomized Trial N/A
Recruiting NCT05121844 - Use of Continuous Glucose Monitoring in Non-Diabetic Population to Compliment Signos Mobile Health Platform N/A
Recruiting NCT05874635 - Signos DM2 Empowerment Study (SIGNOS-CGM-EMPOWER-201-2022) N/A
Withdrawn NCT03120390 - Physical Activity in Reducing Metabolic Dysregulation (MetD) in Obese Latina Breast Cancer Survivors N/A
Completed NCT04152213 - The Effects of Low Glycemic Index (GI) Diet on Cardiometabolic Outcomes Among Obese Chinese Adults N/A
Completed NCT04761081 - Is Physical Activity, Obesity, and Ethnicity Associated With the Tethering and Migration of Pro-inflammatory Monocytes?
Completed NCT02987595 - Effects of Lignan-rich Diet on Cardiometabolic Risk Factors N/A
Not yet recruiting NCT03552237 - Effect of Dietary Fiber Supplement on the Intestinal Microbiota Among Schizophrenia Patients N/A
Recruiting NCT06024018 - Effect of High Intensity Electromagnetic Body Shaping on Profile of Metabolism in Obese Men N/A
Withdrawn NCT03091842 - Exercise Intervention in Targeting Adiposity and Inflammation With Movement to Improve Prognosis in Breast Cancer N/A
Completed NCT02320760 - Physical Activity on Prescription in Overweight Older Adults N/A
Active, not recruiting NCT03912272 - 12-Month Once-a-week HIIT Improves Body Adiposity and Liver Fat N/A
Completed NCT02010060 - Aerobic Training and Non-Exercise Physical Activity N/A
Completed NCT03815253 - Electro-acupuncture for Central Obesity N/A
Completed NCT01445730 - Fructose Consumption and Metabolic Dysregulation N/A
Completed NCT03279432 - Vitamin D-related Genes and Metabolic Disorders N/A